TNFα in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device

Transplant Immunology

Volumn 19, Issue 1, 2008, Pages 64-68

  Bruggink, A H ^a   van Oosterhout, M F M ^a   De Jonge, N ^a   Gmelig Meyling, F H J ^a   De Weger, R A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Heart transplantation; LVAD; Promoter gene polymorphism; TNF

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; BLOOD LEVEL; CARDIAC GRAFT REJECTION; CARDIAC PATIENT; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; GENE SEQUENCE; GENETIC POLYMORPHISM; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; ORGAN DONOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; BLOOD; GENETICS; GENOTYPE; GRAFT REJECTION; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MIDDLE AGED; PROMOTER REGION;

ADULT; ALLELES; GENOTYPE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 40849094218     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.01.001     Document Type: Article

References (41)

1. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldman A.M., Francis G.S., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. J Heart Lung Transplant 21 (2002) 189-203
2. Bruggink A.H., de Jonge N., van Oosterhout M.F., van Wichen D.F., de Koning E., Lahpor J.R., et al. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device. J Heart Lung Transplant 25 (2006) 174-180
3. Bruggink A.H., van Oosterhout M.F., de Jonge N., Ivangh B., van Kuik J., Voorbij R.H., et al. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. J Heart Lung Transplant 25 (2006) 1091-1098
4. de Jonge N., van Wichen D.F., Schipper M.E., Lahpor J.R., Gmelig-Meyling F.H., Robles de Medina E.O., et al. Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments. J Am Coll Cardiol 39 (2002) 963-969
5. Ferrari R. Tumor necrosis factor in CHF: a double facet cytokine. Cardiovasc Res 37 (1998) 554-559
6. van Riemsdijk-van Overbeeke I.C., Baan C.C., Niesters H.G., Hesse C.J., Loonen E.H., Balk A.H., et al. The TNF-alpha system in heart failure and after heart transplantation: plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity. Eur Heart J 20 (1999) 833-840
7. Henriksen P.A., and Newby D.E. Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart. Heart 89 (2003) 14-18
8. Doyama K., Fujiwara H., Fukumoto M., Tanaka M., Fujiwara Y., Oda T., et al. Tumour necrosis factor is expressed in cardiac tissues of patients with heart failure. Int J Cardiol 54 (1996) 217-225
9. Satoh M., Nakamura M., Tamura G., Makita S., Segawa I., Tashiro A., et al. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. J Am Coll Cardiol 29 (1997) 716-724
10. Torre-Amione G., Kapadia S., Lee J., Durand J.B., Bies R.D., Young J.B., et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93 (1996) 704-711
11. Kurrelmeyer K.M., Michael L.H., Baumgarten G., Taffet G.E., Peschon J.J., Sivasubramanian N., et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci U S A 97 (2000) 5456-5461
12. Nakano M., Knowlton A.A., Dibbs Z., and Mann D.L. Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte. Circulation 97 (1998) 1392-1400
13. Suffredini A.F., Fromm R.E., Parker M.M., Brenner M., Kovacs J.A., Wesley R.A., et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321 (1989) 280-287
14. Pagani F.D., Baker L.S., Hsi C., Knox M., Fink M.P., and Visner M.S. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest 90 (1992) 389-398
15. Semb H., Peterson J., Tavernier J., and Olivecrona T. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 262 (1987) 8390-8394
16. Irwin M.W., Mak S., Mann D.L., Qu R., Penninger J.M., Yan A., et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99 (1999) 1492-1498
17. Beraun Y., Nieto A., Collado M.D., Gonzalez A., and Martin J. Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease. Tissue Antigens 52 (1998) 81-83
18. Fanning G.C., Bunce M., Black C.M., and Welsh K.I. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha. Tissue Antigens 50 (1997) 23-31
19. Turner D.M., Grant S.C., Lamb W.R., Brenchley P.E., Dyer P.A., Sinnott P.J., et al. A genetic marker of high TNF-alpha production in heart transplant recipients. Transplantation 60 (1995) 1113-1117
20. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., and Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94 (1997) 3195-3199
21. Andreone P.A., Olivari M.T., Elick B., Arentzen C.E., Sibley R.K., Bolman R.M., et al. Reduction of infectious complications following heart transplantation with triple-drug immunotherapy. J Heart Transplant 5 (1986) 13-19
22. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 9 (1990) 587-593
23. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
24. Deng M.C., Edwards L.B., Hertz M.I., Rowe A.W., Keck B.M., Kormos R., et al. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report-2005. J Heart Lung Transplant 24 (2005) 1182-1187
25. Frazier O.H., and Myers T.J. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg 68 (1999) 734-741
26. Hetzer R., Muller J., Weng Y., Wallukat G., Spiegelsberger S., and Loebe M. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg 68 (1999) 742-749
27. Jaski B.E., Lingle R.J., Reardon L.C., and Dembitsky W.P. Left ventricular assist device as a bridge to patient and myocardial recovery. Prog Cardiovasc Dis 43 (2000) 5-18
28. Dandel M., Weng Y., Siniawski H., Potapov E., Lehmkuhl H.B., and Hetzer R. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation 112 (2005) I37-I45
29. Muller J., Wallukat G., Weng Y.G., DAndel M., Spiegelsberger S., Semrau S., et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation 96 (1997) 542-549
30. de Jonge N., Kirkels H., Lahpor J.R., Klopping C., Hulzebos E.J., de la Riviere A.B., et al. Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting?. J Am Coll Cardiol 37 (2001) 1794-1799
31. Burkhoff D., Holmes J.W., Madigan J., Barbone A., and Oz M.C. Left ventricular assist device-induced reverse ventricular remodeling. Prog Cardiovasc Dis 43 (2000) 19-26
32. Estrada-Quintero T., Uretsky B.F., Murali S., Griffith B.P., and Kormos R.L. Neurohormonal activation and exercise function in patients with severe heart failure and patients with left ventricular assist system. A comparative study. Chest 107 (1995) 1499-1503
33. Baan C.C., Niesters H.G., Balk A.H., Mochtar B., Zondervan P.E., and Weimar W. The intragraft cytokine mRNA pattern reflects the efficacy of steroid antirejection therapy. J Heart Lung Transplant 15 (1996) 1184-1193
34. Van Hoffen E., Van Wichen D., Stuij I., de Jonge N., Klopping C., Lahpor J., et al. In situ expression of cytokines in human heart allografts. Am J Pathol 149 (1996) 1991-2003
35. Zhao X.M., Yeoh T.K., Hiebert M., Frist W.H., and Miller G.G. The expression of acidic fibroblast growth factor (heparin-binding growth factor-1) and cytokine genes in human cardiac allografts and T cells. Transplantation 56 (1993) 1177-1182
36. Sankaran D., Asderakis A., Ashraf S., Roberts I.S., Short C.D., Deyer P.A., et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56 (1999) 281-288
37. Turner D.M., Sankaran D., and Grant S.C.D. The effect of polymorphism in the TNF-alpha and IL-10 genes on heart transplant rejection. J Heart Lung Transplant 16 (1997) 108
38. Hutchinson I.V., Turner D.M., Sankaran D., Awad M.R., and Sinnott P.J. Influence of cytokine genotypes on allograft rejection. Transplant Proc 30 (1998) 862-863
39. Awad M.R., Webber S., Boyle G., Sturchioc C., Ahmed M., Martell J., et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 20 (2001) 625-630
40. Bedi M., Postava L.A., Murali S., MacGowan G.A., Mathier M., Shears L., et al. Effect of the TNF-alpha-promoter polymorphism on cardiac allograft rejection. J Heart Lung Transplant 23 (2004) 696-700
41. Holweg C.T., Weimar W., Uitterlinden A.G., and Baan C.C. Clinical impact of cytokine gene polymorphisms in heart and lung transplantation. J Heart Lung Transplant 23 (2004) 1017-1026